RE: RNS update this am28 May 2020 08:59
Daz, you could look at AFC and think that at this price it really is good value. There is no reason why it cannot achieve the MCap of ITM once they start to receive orders. What AFC have achieved with no debt and a small number of shares is incredible. It should be easy for AFC to become profitable as the cells are low cost to manufacture, they do not have the overheads of a production/manufacturing facility (why would you want this if your system is designed with low cost of the shelf components) and they appear to be generating good relationships with their supply chain. Business model offers great potential and value